| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
46,977 |
36,459 |
$1.36M |
| 82075 |
|
13,355 |
8,049 |
$294K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,848 |
6,639 |
$200K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,366 |
3,058 |
$186K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
8,640 |
7,685 |
$149K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,064 |
5,980 |
$129K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
3,410 |
2,878 |
$114K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,029 |
4,290 |
$99K |
| 80305 |
|
7,775 |
6,593 |
$74K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,813 |
3,478 |
$67K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,386 |
1,224 |
$54K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,595 |
1,464 |
$54K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,925 |
5,434 |
$54K |
| 81025 |
|
3,029 |
2,590 |
$18K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
66 |
57 |
$5K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
578 |
521 |
$3K |
| 99490 |
Ccm add 20min |
563 |
370 |
$2K |
| 90674 |
|
106 |
93 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
88 |
76 |
$1K |
| 87807 |
|
126 |
119 |
$861.57 |
| 99441 |
|
27 |
25 |
$662.57 |
| H0049 |
Alcohol and/or drug screening |
62 |
54 |
$542.47 |
| H0031 |
Mental health assessment, by non-physician |
18 |
16 |
$443.62 |
| 99051 |
|
40 |
30 |
$322.50 |
| 81000 |
|
275 |
256 |
$307.22 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
17 |
17 |
$116.73 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
17 |
12 |
$105.70 |
| 99439 |
|
18 |
12 |
$54.24 |
| 81002 |
|
19 |
18 |
$10.61 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
13 |
12 |
$8.69 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
29 |
27 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
759 |
615 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
13 |
12 |
$0.00 |